1
|
Sampson C. NICE and the EQ-5D-5L: Ten Years Trouble. PHARMACOECONOMICS - OPEN 2022; 6:5-8. [PMID: 34910293 PMCID: PMC8807740 DOI: 10.1007/s41669-021-00315-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Accepted: 11/21/2021] [Indexed: 06/14/2023]
|
2
|
Whitehurst DGT, Brazier JE, Viney R, Mulhern BJ. The SF-6Dv2: How Does the New Classification System Impact the Distribution of Responses Compared with the Original SF-6D? PHARMACOECONOMICS 2020; 38:1283-1288. [PMID: 32909144 DOI: 10.1007/s40273-020-00957-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/18/2023]
Affiliation(s)
- David G T Whitehurst
- Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
- Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada.
- Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, NSW, Australia.
| | - John E Brazier
- Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, UK
| | - Rosalie Viney
- Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, NSW, Australia
| | - Brendan J Mulhern
- Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, NSW, Australia
- Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, UK
| |
Collapse
|
3
|
Ben Â, Finch AP, van Dongen JM, de Wit M, van Dijk SEM, Snoek FJ, Adriaanse MC, van Tulder MW, Bosmans JE. Comparing the EQ-5D-5L crosswalks and value sets for England, the Netherlands and Spain: Exploring their impact on cost-utility results. HEALTH ECONOMICS 2020; 29:640-651. [PMID: 32059078 DOI: 10.1002/hec.4008] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/04/2019] [Revised: 12/14/2019] [Accepted: 01/21/2020] [Indexed: 06/10/2023]
Abstract
This study compares the five-level EuroQol five-dimension questionnaire (EQ-5D-5L) crosswalks and the 5L value sets for England, the Netherlands, and Spain and explores the implication of using one or the other for the results of cost-utility analyses. Data from two randomized controlled trials in depression and diabetes were used. Utility value distributions were compared, and mean differences in utility values between the EQ-5D-5L crosswalk and the 5L value set were described by country. Quality-adjusted life years (QALYs) were calculated using the area-under-the-curve method. Incremental cost-effectiveness ratios (ICERs) were calculated, and uncertainty around ICERs was estimated using bootstrapping and graphically shown in cost-effectiveness acceptability curves. For all countries investigated, utility value distributions differed between the EQ-5D-5L crosswalk and 5L value set. In both case studies, mean utility values were lower for the EQ-5D-5L crosswalk compared with the 5L value set in England and Spain, but higher in the Netherlands. However, these differences in utility values did not translate into relevant differences across utility estimation methods in incremental QALYs and the interventions' probability of cost-effectiveness. Thus, our results suggest that EQ-5D-5L crosswalks and 5L value sets can be used interchangeably in patients affected by mild or moderate conditions. Further research is needed to establish whether these findings are generalizable to economic evaluations among severely ill patients.
Collapse
Affiliation(s)
- Ângela Ben
- Health Technology Assessment Section, Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Aureliano Paolo Finch
- Health Technology Assessment Section, Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Johanna M van Dongen
- Health Technology Assessment Section, Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Maartje de Wit
- Department of Medical Psychology, Amsterdam University Medical Centers - VUmc, Amsterdam, The Netherlands
| | - Susan E M van Dijk
- Health Technology Assessment Section, Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Frank J Snoek
- Department of Medical Psychology, Amsterdam University Medical Centers - VUmc, Amsterdam, The Netherlands
| | - Marcel C Adriaanse
- Health Technology Assessment Section, Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Maurits W van Tulder
- Health Technology Assessment Section, Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Judith E Bosmans
- Health Technology Assessment Section, Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| |
Collapse
|
5
|
Whitehurst DGT, Latimer NR, Kagan A, Palmer R, Simmons-Mackie N, Victor JC, Hoch JS. Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom. PHARMACOECONOMICS - OPEN 2018; 2:225-231. [PMID: 29802576 PMCID: PMC6103929 DOI: 10.1007/s41669-018-0083-2] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
A key component of the current framework for economic evaluation is the measurement and valuation of health outcomes using generic preference-based health-related quality-of-life (HRQoL) instruments. In 2015, a research synthesis reported the absence of conceptual and empirical research regarding the appropriateness of current preference-based instruments for people with aphasia-a disorder affecting the use and understanding of language-and suggested the development and validation of an accessible, pictorial variant could be an appropriate direction for further research. This paper describes the respective rationale and development process for each of three preliminary studies that have been undertaken to develop pictorial variants of two widely used preference-based HRQoL instruments (EQ-5D-3L and EQ-5D-5L). The paper also proposes next steps for this program of research, drawing on the lessons learned from the preliminary work and the demand for a pictorial preference-based instrument in the research community. Guidance for the use of the preliminary, pictorial instruments is also provided.
Collapse
Affiliation(s)
- David G T Whitehurst
- Faculty of Health Sciences, Blusson Hall, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A 1S6, Canada.
- Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, 7th Floor, 828 West 10th Avenue, Vancouver, BC, V5Z 1M9, Canada.
- International Collaboration on Repair Discoveries (ICORD), Faculty of Medicine, University of British Columbia, 818 West 10th Avenue, Vancouver, BC, V5Z 1M9, Canada.
| | - Nicholas R Latimer
- Health Economics and Decision Science, School of Health and Related Research, The University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, England, UK
| | - Aura Kagan
- Aphasia Institute, The Pat Arato Aphasia Centre, 73 Scarsdale Road, Toronto, ON, M3B 2R2, Canada
| | - Rebecca Palmer
- Health Services Research, School of Health and Related Research, The University of Sheffield, Innovation Centre, 217 Portobello, Sheffield, S1 4DP, England, UK
| | - Nina Simmons-Mackie
- Department of Health and Human Sciences, Southeastern Louisiana University, 310 West Dakota Street, Hammond, LA, USA
| | - J Charles Victor
- Institute for Health Policy Management and Evaluation, University of Toronto, Health Sciences Building, 155 College St, Suite 425, Toronto, ON, M5T 3M6, Canada
| | - Jeffrey S Hoch
- Department of Public Health Sciences, 1 Shields Avenue, Med Sci 1-C, University of California, Davis, Davis, California, 95616-8638, USA
- Center for Healthcare Policy and Research, 2103 Stockton Blvd., Sacramento, CA, 95817, USA
| |
Collapse
|
6
|
Round J. Once Bitten Twice Shy: Thinking Carefully Before Adopting the EQ-5D-5L. PHARMACOECONOMICS 2018; 36:641-643. [PMID: 29498001 DOI: 10.1007/s40273-018-0636-3] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Affiliation(s)
- Jeff Round
- Department of Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, BS8 2PS, Bristol, UK.
| |
Collapse
|